Your browser doesn't support javascript.
loading
No Consistent Antidepressant Effects of Deep Brain Stimulation of the Bed Nucleus of the Stria Terminalis.
Fitzgerald, Paul B; Hoy, Kate; Richardson, Karyn E; Gainsford, Kirsten; Segrave, Rebecca; Herring, Sally E; Daskalakis, Zafiris J; Bittar, Richard G.
Afiliación
  • Fitzgerald PB; School of Medicine and Psychology, Australian National University, Canberra, ACT 2601, Australia.
  • Hoy K; Bionics Institute of Australia, East Melbourne, Melbourne, VIC 3002, Australia.
  • Richardson KE; BrainPark, Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3168, Australia.
  • Gainsford K; School of Medicine and Psychology, Australian National University, Canberra, ACT 2601, Australia.
  • Segrave R; BrainPark, Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3168, Australia.
  • Herring SE; Monash Biomedical Imaging, Monash University, Clayton, VIC 3168, Australia.
  • Daskalakis ZJ; Bionics Institute of Australia, East Melbourne, Melbourne, VIC 3002, Australia.
  • Bittar RG; Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA.
Brain Sci ; 14(5)2024 May 15.
Article en En | MEDLINE | ID: mdl-38790480
ABSTRACT

BACKGROUND:

Applying deep brain stimulation (DBS) to several brain regions has been investigated in attempts to treat highly treatment-resistant depression, with variable results. Our initial pilot data suggested that the bed nucleus of the stria terminalis (BNST) could be a promising therapeutic target.

OBJECTIVE:

The aim of this study was to gather blinded data exploring the efficacy of applying DBS to the BNST in patients with highly refractory depression.

METHOD:

Eight patients with chronic severe treatment-resistant depression underwent DBS to the BNST. A randomised, double-blind crossover study design with fixed stimulation parameters was followed and followed by a period of open-label stimulation.

RESULTS:

During the double-blind crossover phase, no consistent antidepressant effects were seen with any of the four stimulation parameters applied, and no patients achieved response or remission criteria during the blinded crossover phase or during a subsequent period of three months of blinded stimulation. Stimulation-related side effects, especially agitation, were reported by a number of patients and were reversible with adjustment of the stimulation parameters.

CONCLUSIONS:

The results of this study do not support the application of DBS to the BNST in patients with highly resistant depression or ongoing research utilising stimulation at this brain site. The blocked randomised study design utilising fixed stimulation parameters was poorly tolerated by the participants and does not appear suitable for assessing the efficacy of DBS at this location.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Brain Sci Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Brain Sci Año: 2024 Tipo del documento: Article País de afiliación: Australia